BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19579640)

  • 1. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
    Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
    Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
    Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
    Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
    Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
    Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lentinan combination therapy for unresectable advanced gastric cancer.
    Higashi D; Seki K; Ishibashi Y; Egawa Y; Koga M; Sasaki T; Hirano K; Mikami K; Futami K; Maekawa T; Sudo M
    Anticancer Res; 2012 Jun; 32(6):2365-8. PubMed ID: 22641676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)].
    Tanaka A; Funai S; Ohtsuka H; Yoshifuji T; Hirai T; Shindo K; Shiozaki H; Kamei A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1347-50. PubMed ID: 14518419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
    Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
    Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
    Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
    Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of S-1 combined with weekly Paclitaxel for gastric cancer with cancerous ascites].
    Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1815-8. PubMed ID: 18030015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
    Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
    Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
    Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced gastric cancer with Schnitzler's metastases effectively treated by the combination of paclitaxel and S-1].
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
    Gan To Kagaku Ryoho; 2008 May; 35(5):829-31. PubMed ID: 18487923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
    Ishigami S; Nakajo A; Uenosono Y; Okumura H; Matsumoto M; Arigami T; Uchikado Y; Setoyama T; Hokita S; Natsugoe S; Aikou T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):569-72. PubMed ID: 17431343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.